MOLLY HOCKIN: Open Payments
NPI 1003542382 · AKRON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$632 in 32 payments from 10 companies in 2025. Trend: 2023 $35 · 2024 $0 · 2025 $632
Food & beverage: $632
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 6 | $174 |
| Janssen Pharmaceuticals, Inc | 4 | $84 |
| Indivior Inc. | 4 | $68 |
| Lundbeck LLC | 4 | $66 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $52 |
| Axsome Therapeutics, Inc. | 3 | $43 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| ABBVIE INC. | 2 | $30 |
| Alkermes, Inc. | 1 | $15 |
Products named: FANAPT, INVEGA SUSTENNA, SUBLOCADE, ABILIFY MAINTENA, CAPLYTA, Auvelity, REXULTI, COBENFY.
Industry payments across OH — which companies pay providers there.
